Read + Share
Jiang X, Chen J, Zheng M, Jia H, et al. Cost-effectiveness analysis of durvalumab as a maintenance treatment for patients
with locally advanced, unresectable, stage nsclc in china. PLoS One 2022;17:e0270118.
PMID: 35749385
|
 |
|
Jiang X, Chen J, Zheng M, Jia H, et al. Cost-effectiveness analysis of durvalumab as a maintenance treatment for patients
with locally advanced, unresectable, stage nsclc in china. PLoS One 2022;17:e0270118.
PMID: 35749385
|
|
|
|